Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 8, 2012, Pages 736-743

  Maguilnik, I ^a   Neumann, W L ^b,c   Sonnenberg, A ^d,e   Genta, R M ^b,c,f  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b MIRACA LIFE SCIENCES   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHILD; COHORT ANALYSIS; COLITIS; COLLAGENOUS COLITIS; COLON BIOPSY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DUODENAL LYMPHOCYTOSIS; DUODENITIS; DUODENUM BIOPSY; ESOPHAGUS BIOPSY; FEMALE; FOCAL COLITIS; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEITIS; INFANT; INTESTINE BIOPSY; INTESTINE METAPLASIA; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; NONHUMAN; PRIORITY JOURNAL; REACTIVE GASTROPATHY; RISK FACTOR; STOMACH BIOPSY; STOMACH DISEASE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENTERITIS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HUMANS; INFANT; INTESTINAL MUCOSA; MALE; MIDDLE AGED; STOMACH DISEASES; UNITED STATES; YOUNG ADULT;

EID: 84866396203     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12031     Document Type: Article

References (38)

1. Bensley EH,. Alexis St Martin. Can Med Assoc J 1959; 80: 907-9.
2. Cotton PB, Rosenberg MT, Axon AT, et al,. Diagnostic yield of fibre-optic endoscopy in the operated stomach. Br J Surg 1973; 60: 629-32.
3. Krentz K,. Gastroscopic and aspiration biopsy findings on the operated stomach. Dtsch Med Wochenschr 1964; 89: 664-71.
4. Lechner HJ, Anton D,. The histology of gastric mucosa in B II-stomach. Z Gastroenterol 1979; 17: 674-9.
5. Mosimann F, Sorgi M, Wolverson RL, Alexander-Williams J, Donovan IA, Harding LK,. Bile reflux after duodenal ulcer surgery. A study of 114 asymptomatic and symptomatic patients. Scand J Gastroenterol Suppl 1984; 92: 224-6.
6. Langhans P, Bues M, Bunte H,. Morphological changes in the operated stomach under the influence of duodenogastric reflux. Clinical follow-up over 20 years. Scand J Gastroenterol Suppl 1984; 92: 145-8.
7. Langhans P, Heger RA, Stegemann B,. The cancer risk in the stomach subjected to nonresecting procedures. An experimental long-term study. Scand J Gastroenterol Suppl 1984; 92: 138-41.
8. Offerhaus GJ, Stadt J, Huibregtse K, Tytgat G,. Endoscopic screening for malignancy in the gastric remnant: the clinical significance of dysplasia in gastric mucosa. J Clin Pathol 1984; 37: 748-54.
9. Offerhaus GJ, Huibregtse K, de BJ, et al,. The operated stomach: a premalignant condition? A prospective endoscopic follow-up study. Scand J Gastroenterol 1984; 19: 521-4.
10. Dewar EP, Dixon MF, Johnston D,. Bile reflux and degree of gastritis after highly selective vagotomy, truncal vagotomy, and partial gastrectomy for duodenal ulcer. World J Surg 1983; 7: 743-50.
11. Dewar P, Dixon MF, Johnston D,. Bile reflux and degree of gastritis in patients with gastric ulcer: before and after operation. J Surg Res 1984; 37: 277-84.
12. Dixon MF, O'Connor HJ, Axon AT, King RF, Johnston D,. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986; 39: 524-30.
13. Sobala GM, O'Connor HJ, Dewar EP, King RF, Axon AT, Dixon MF,. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 1993; 46: 235-40.
14. Dixon MF, Genta RM, Yardley JH, Correa P,. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
15. Genta RM,. Differential diagnosis of reactive gastropathy. Semin Diagn Pathol 2005; 22: 273-83.
16. Genta RM, Kinsey RS, Singhal A, Suterwala S,. Gastric foveolar metaplasia and gastric heterotopia in the duodenum: no evidence of an etiologic role for Helicobacter pylori. Hum Pathol 2010; 41: 1593-600.
17. Carmack SW, Lash RH, Gulizia JM, Genta RM,. Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol 2009; 16: 290-306.
18. Cryer B, Feldman M,. Peptic ulcer disease in the elderly. Semin Gastrointest Dis 1994; 5: 166-78.
19. Graham DY,. The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease. Gastroenterol Clin North Am 1990; 19: 171-82.
20. Griffin MR, Ray WA, Schaffner W,. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359-63.
21. El-Zimaity HM, Genta RM, Graham DY,. Histological features do not define NSAID-induced gastritis. Hum Pathol 1996; 27: 1348-54.
22. Lazenby AJ,. Collagenous and lymphocytic colitis. Semin Diagn Pathol 2005; 22: 295-300.
23. Pardi DS, Ramnath VR, Loftus EV Jr, Tremaine WJ, Sandborn WJ,. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 2002; 97: 2829-33.
24. Amano Y, Kushiyama Y, Takahashi Y, Ishihara S, Adachi K, Kinoshita Y,. Prevalence of ileo-colonic ulcerative lesions in chronic NSAIDs users. Am J Gastroenterol 2004; 99: 1193.
25. Lengeling RW, Mitros FA, Brennan JA, Schulze KS,. Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents. Clin Gastroenterol Hepatol 2003; 1: 160-9.
26. Smale S, Tibble J, Sigthorsson G, Bjarnason I,. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol 2001; 15: 723-38.
27. Giardiello FM, Hansen FC III, Lazenby AJ, et al,. Collagenous colitis in setting of nonsteroidal antiinflammatory drugs and antibiotics. Dig Dis Sci 1990; 35: 257-60.
28. Kakar S, Pardi DS, Burgart LJ,. Colonic ulcers accompanying collagenous colitis: implication of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 2003; 98: 1834-7.
29. Greenson JK, Stern RA, Carpenter SL, Barnett JL,. The clinical significance of focal active colitis. Hum Pathol 1997; 28: 729-33.
30. Goldstein NS, Cinenza AN,. The histopathology of nonsteroidal anti-inflammatory drug-associated colitis. Am J Clin Pathol 1998; 110: 622-8.
31. Chande N, Driman DK, Reynolds RP,. Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scand J Gastroenterol 2005; 40: 343-7.
32. Filik L,. Collagenous colitis and nonsteroidal anti-inflammatory drugs. Eur J Intern Med 2010; 21: e11.
33. Milman N, Kraag G,. NSAID-induced collagenous colitis. J Rheumatol 2010; 37: 2432-3.
34. Haque S, Genta RM,. Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut 2012; 61: 1108-14.
35. Dellon ES, Peery AF, Shaheen NJ, et al,. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology 2011; 141: 1586-92.
36. Dixon MF, Neville PM, Mapstone NP, Moayyedi P, Axon AT., Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut 2001; 49: 359-63.
37. Ford AC, Moayyedi P, Jarbol DE, Logan RF, Delaney BC,. Meta-analysis: Helicobacter pylori 'test and treat' compared with empirical acid suppression for managing dyspepsia. Aliment Pharmacol Ther 2008; 28: 534-44.
38. Moayyedi P, Soo S, Deeks J, et al,. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 2: CD002096.